Incidence of COVID-19 in Patients With Chronic Idiopathic Urticaria and Asthma on Omalizumab: A Multicentre Retrospective Cohort Study

J Cutan Med Surg. 2022 May-Jun;26(3):319-320. doi: 10.1177/12034754211049707. Epub 2021 Sep 29.

¹ 6221 Faculty of Medicine, University of Western Ontario, London, Canada.
² 7938 Division of Dermatology, Department of Medicine, University of Toronto, ON, Canada.
³ Skin Health & Wellness Centre, Calgary, AB, Canada.
⁴ 468790 SKiN Centre for Dermatology, Peterborough, ON, Canada.
⁵ Department of Dermatology and Skin Science, University of British Columbia, Vancouver, BC, Canada.
⁶ 3710 Division of Clinical Immunology and Allergy, McMaster University, Hamilton, ON, Canada.
⁷ Division of Dermatology, Department of Medicine, Sunnybrook Health Sciences Centre, Toronto, ON, Canada.
⁸ Department of Dermatology, McMaster University, Hamilton, ON, Canada.
⁹ 70401 Division of Dermatology, Department of Medicine, University of Calgary, AB, Canada.
¹⁰ Department of Dermatology, Women's College Hospital, Toronto, ON, Canada.

No abstract available

Keywords: COVID-19; SARS-CoV-2; asthma; dermatology; omalizumab; urticaria.

Publication types